Introduction
Cardiac troponins are sensitive markers of myocardial damage and are also powerful prognostic indicators of adverse cardiac events. With advances in technology, a new era in troponin assays has started. The ability of the high-sensitive troponin T (hscTnT) assay to detect troponin T elevation in blood within two hours and with higher sensitivity after a myocardial insult led to the replacement of former troponin assays. However, conventional cardiac troponin T and I concentrations might be elevated in newborns despite a normal cardiovascular state (Adamcová et al. 1995) . To date, there is limited information on high-sensitive troponin I in children (Caselli et al. 2016 ). However, there are no reliable data regarding hscTnT reference levels in newborns and infants. The primary aim of this study was to determine the hscTnT distribution in healthy neonates. The secondary objective was to correlate hscTnT with birth weight, blood gases, degree of haemolysis in neonates and to assess changes of hscTnT concentrations during early infancy.
Methods
This study was approved by the local Ethics Committee and performed according to the principles of the Declaration of Helsinki. After written informed consent was obtained from legal guardians, 454 full-term healthy newborns were enrolled in the study. All subjects were recruited from the single neonatology department at the university hospital. Exclusion criteria included an Apgar score less than 8 points performed at standard intervals of time after birth, the presence of congenital defects or infection, and a history of chronic medication or drug abuse in the mother.
Samples of cord blood were drawn in the tube with lithium heparin as a blood anticoagulant and tested for hscTnT concentrations and blood gases. The electrochemiluminescent (ECLIA) method was used to assess the hscTnT concentration (Roche Cobas e602 immunochemical analyser). The level of haemolysis was measured by a photometrical Cobas 8000 analyser. Samples with haemolysis higher than 1 g/l (haemolysis index ≥ 2) were excluded from further analysis, respecting the recommendations of the analytical manufacturer. Blood gases and acid-base balance analysis were performed using a GEM 3500 analyser according to the standardised methodology of the university hospital.
HscTnT concentrations were not normally distributed and therefore the medians and interquartile ranges are reported and non-parametric comparisons were made. We constructed a reference range of cardiac troponin T concentrations and calculated the upper limit in the population (97.5th centile).
Differences among groups were examined by the Mann-Whitney test. Correlations among hsTnT and other parameters (birth weight, level of haemolysis, umbilical cord acid base status) were analysed using the rank correlation coefficient. A p-value of 0.05 or less was considered statistically significant.
Results
Cord blood samples were taken from 454 healthy newborns; 213 samples were excluded due to a blood haemolysis index ≥ 2. The subset of 241 samples was statistically analysed ( Table 1 Haemolysis is known to negatively interfere in hscTnT assays. Up to 45% of our samples contained some degree of haemolysis. This result is in agreement with a former study (Li et al. 2013) and it is of critical importance when interpreting hscTnT concentration. A haemoglobin concentration of 1.9 g/L 6 or higher might decrease the hscTnT level up to 20%. We found a significant reduction in the hscTnT concentration at haemoglobin concentrations ≥2.0g/l (haemolysis index ≥ 3). Consideration of preanalytical variables is essential, such as time interval from blood sampling to laboratory analysis. A significant decline in the hscTnT concentration over time has been reported (Li et al. 2013) . The acceleration in haemolysis might be explained by the release of erythrocyte proteases, causing a disruption in the TnT-epitope used in the diagnostic kit.
Higher hscTnT concentrations in boys when compared to girls in our study are in contrast to results of previous study using the conventional troponin T assay (Baum et al. 2004) . However, this small difference in hscTnT concentrations has no clinical relevance.
Strengths and limitations
Our study was conducted on a quite large number of neonates. Despite excluding up to 45% of samples due to haemolysis (haemolysis index ≥ 2), a distribution curve was constructed with sufficient statistical power. On the other hand, probands were not followed-up after study. A longitudinal study would require repeated blood sampling in healthy infants which is ethically questionable.
Conclusion
Substantially higher reference plasma concentrations of hscTnT in neonates and young infants when compared with the adult population require careful clinical interpretation. It is advised to consider many extracardiac factors as haemolysis and age that might affect the hscTnT levels in these children. 
